Wiley Michael J 4
4 · Guardant Health, Inc. · Filed Dec 26, 2019
Insider Transaction Report
Form 4
Wiley Michael J
Chief Legal Officer
Transactions
- Gift
COMMON STOCK
2019-12-23−14,416→ 115,321 total - Exercise/Conversion
COMMON STOCK
2019-12-23$4.18/sh+6,148$25,699→ 121,469 total - Sale
COMMON STOCK
2019-12-23$81.91/sh−1,957$160,298→ 116,821 total - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2019-12-23−6,148→ 100,633 totalExercise: $4.18Exp: 2027-07-13→ COMMON STOCK (6,148 underlying) - Sale
COMMON STOCK
2019-12-23$80.89/sh−2,691$217,675→ 118,778 total - Sale
COMMON STOCK
2019-12-23$82.75/sh−1,500$124,125→ 115,321 total
Footnotes (6)
- [F1]Represents shares of Common Stock that the Reporting Person donated as a gift to a donor advised fund administered by the Deseret Trust Company.
- [F2]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.50 to $81.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.51 to $82.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.52 to $83.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.